• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep26
Distribution Plan(EST)

Cash dividend 0.0957 USD

Sep22
Distribution Plan(EST)

Cash dividend 0.0957 USD

Distribution Plan(EST)

Cash dividend 0.0957 USD

View More

Event Tracking

Dec16
LEQEMBI Added to China's Commercial Insurance List of Innovative Drugs
16:17
Jefferies Analyst Maintains Buy Rating for Argenx Se with Price Target at $950
15:27
Cantor Fitzgerald Maintains Buy Rating on Insmed
14:54
Aliraum Pharmaceuticals' AMVUTTRA® Approved by Health Canada
14:37
Stifel Nicolaus analyst maintains buy rating on Biogen
08:22
AstraZeneca's Saphnelo approved for treating systemic lupus erythematosus
07:08